Recommended

Teva close to API business sale
Streamlined rAAV purification enables efficient upstream analytics – access now
First new IPF treatment in US for a decade
Webinar: Radiopharmaceuticals’ time-to-result challenge
AstraZeneca/Daiichi cancer drug boost
Takeda to move away from cell therapy
GSK appoints new CEO
Advertorial

Shimadzu Corporation collaborates with PREMIER Biosoft to launch a comprehensive lipid and glycan analysis platform using Shimadzu’s new Q-TOF Mass Spectrometer

2
SHARES

Posted: 20 June 2018 | | No comments yet

Redefines Lipidomics and Glycomics Research with Shimadzu’s LCMS-9030 Q-TOF Mass Spectrometer…

Shimadzu, one of the world’s fastest growing mass spectrometry companies, and PREMIER Biosoft, a global leader in offering bioinformatics solutions to life sciences laboratories, today announced the introduction of Shimadzu’s LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry (MS) system with informatics support powered by PREMIER Biosoft’s software solutions for lipidomics and glycomics data analysis. Shimadzu and PREMIER Biosoft said they will support the combination of each other’s technologies to advance lipidomics and glycomics research.

 

Reserve your FREE place

 


Address the time-to-result challenge posed by short shelf-life radiopharmaceuticals.

20 November 2025 | 3:00 PM GMT | FREE Virtual Panel Discussion

This webinar showcases the Growth Direct System; an RMM (Rapid Microbial Method) that improves on traditional membrane filtration, delivering increased accuracy, a faster time to result, enhanced data integrity compliance, and more control over the manufacturing process.

Key learning points:

  • Understand the benefits of full workflow microbiology quality control testing automation in radiopharmaceutical production
  • Learn about ITM’s implementation journey and considerations when evaluating the technology
  • Find out how the advanced optics and microcolony detection capabilities of Growth Direct® technology impact time to result (TTR).

Don’t miss your chance to learn from experts in the industry – Register for FREE

 

Shimadzu’s high-resolution accurate-mass quadrupole time-of-flight LCMS-9030 used in conjunction with PREMIER Biosoft’s SimLipid and SimGlycan software solutions will allow scientists to perform rapid identification and quantitation of lipids and glycans from complex biological mixtures in high-throughput mode, the firms said. The joint workflows will alleviate the challenges that scientists have been facing in the fields of lipidomics and glycomics.

“The advancement in mass spectrometry technology fuels the development of lipidomics and glycomics methods,”

said Ichiro Hirano, LCMS Product Manager, Shimadzu Corporation.

“Shimadzu’s new Q-TOF technology offers a high level of sensitivity, selectivity and precision, thereby enabling researchers to develop shotgun- and LC-MS workflows for targeted and untargeted lipidomics and glycomics using the advanced lipid and glycan identification and quantitation capabilities provided by PREMIER Biosoft’s SimLipid and SimGlycan software solutions.”

Arun Apte, CEO at PREMIER Biosoft, added,

“Our software products directly read raw data from Shimadzu’s LCMS-9030 instrument, providing seamless data integration, accurate and efficient identification of lipids and glycans, their subsequent quantitation, and finally enabling downstream statistical and pathways analysis.”

Share via
Share via